CoreCap Advisors’s Hims & Hers Health HIMS Stock Holding History

CoreCap Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.4K	Buy	330 +310	+1,550%	+$8.32K	﹤0.01%	2018
2026 Q1	$415	Hold	20	–	–	﹤0.01%	2682
2025 Q4	$649	Sell	20 -2,447	-99%	-$105K	﹤0.01%	2665
2025 Q3	$140K	Sell	2,467 -7,958	-76%	-$408K	0.01%	914
2025 Q2	$520K	Buy	10,425 +9,925	+1,985%	+$449K	0.02%	505
2025 Q1	$14.8K	Buy	500 +352	+238%	+$13.1K	﹤0.01%	1662
2024 Q4	$3.58K	Sell	148 -42,318	-100%	-$1.05M	﹤0.01%	2058
2024 Q3	$782K	Buy	+42,466	New	+$760K	0.04%	361

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CoreCap Advisors's HIMS Position: Q2 2026 in Review

CoreCap Advisors increased its Hims & Hers Health (HIMS) stake by 1,550% in Q2 2026, buying an estimated $8.32K and bringing the position to 330 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2018.

CoreCap Advisors first reported a position in HIMS in Q3 2024 and has held it in 8 quarters since. The position peaked at $782K in Q3 2024. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

CoreCap Advisors held 330 shares of Hims & Hers Health worth $11.4K as of Q2 2026.
CoreCap Advisors bought 310 Hims & Hers Health shares in Q2 2026, an estimated $8.32K.
Hims & Hers Health made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2018 holding.
CoreCap Advisors first reported a position in Hims & Hers Health in Q3 2024 and has held it in 8 quarters since.
CoreCap Advisors's Hims & Hers Health position peaked at $782K in Q3 2024.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.